Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation
NCT03777371 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128
Last updated 2018-12-17
Summary
HIV virus is an etiologic agent of ( AIDS ) immunodeficiency syndrome . It is known that the estimated rate of transfer from mother to baby is 25% to 45%, pregnancy rate is 5-10%, pregnancy rate is 15-20% and in lactation period is 5-10%. Risk factors; maternal viral load, breastfeeding, vaginal birth, and prematurity. Although there is a high rate of false positivity in prenatal screening in our country, one of the factors affecting this is the number of pregnancies.
Conditions
- HIV Seropositivity
- Acquired Immunodeficiency Syndrome
- Pregnancy, High Risk
Interventions
- OTHER
-
Anti HIV Seropositive Pregnant Women
Sponsors & Collaborators
-
Kanuni Sultan Suleyman Training and Research Hospital
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-01
- Primary Completion
- 2018-12-01
- Completion
- 2018-12-01
More Related Trials
-
Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women
NCT00006320 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum
NCT03386578 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
NCT00000910 ·Status: COMPLETED
-
Development of Resistance Mutations in Pregnant HIV-positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
NCT00197366 ·Status: TERMINATED
-
Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women
NCT03227731 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
NCT06158126 ·Status: RECRUITING ·Phase: PHASE4
-
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
NCT03048669 ·Status: COMPLETED ·Phase: NA
-
Primary HIV Prevention in Pregnant and Lactating Ugandan Women
NCT01882998 ·Status: COMPLETED ·Phase: NA
-
A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
NCT00341302 ·Status: COMPLETED
-
Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine
NCT00000828 ·Status: COMPLETED
-
ART Readiness in HIV-infected Pregnant Women
NCT02459678 ·Status: COMPLETED ·Phase: NA
-
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
NCT00000751 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Barriers to Postpartum Care in HIV Infected Women
NCT01853917 ·Status: COMPLETED
-
Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn
NCT04024150 ·Status: COMPLETED
-
Supporting Oral and Long-acting PrEP Decision Making Among Pregnant Women in Lilongwe, Malawi
NCT06397690 ·Status: COMPLETED ·Phase: NA
-
An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women
NCT04330989 ·Status: COMPLETED ·Phase: NA
-
Fetal HIV Transmission Risk and Duration of Membrane Rupture
NCT01616823 ·Status: COMPLETED
-
Screening for TB in Pregnancy. on HIV-Infected Pregnant Women
NCT02520973 ·Status: COMPLETED ·Phase: NA
-
Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study
NCT02245022 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Antiretroviral Drug Levels During and After Pregnancy
NCT00616252 ·Status: COMPLETED
-
Healthy Beginning Initiative
NCT01795261 ·Status: UNKNOWN
-
The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study
NCT04087239 ·Status: ACTIVE_NOT_RECRUITING
-
Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1
NCT06435026 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed
NCT05642481 ·Status: COMPLETED
-
HIV Diagnosis in Hospitalized Malawian Infants
NCT01388452 ·Status: COMPLETED ·Phase: NA